Schiavoni G - Search Results

1

Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade.

Rossi A, Lucarini V, Macchia I, Sestili P, Buccione C, Donati S, Ciccolella M, Sistigu A, D'Urso MT, Pacca AM, Cardarelli E, Mattei F, Proietti E, Schiavoni G, Bracci L. Rossi A, et al. Among authors: schiavoni g. Cells. 2020 Apr 10;9(4):940. doi: 10.3390/cells9040940. Cells. 2020. PMID: 32290265 Free PMC article.

2

Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.

Schiavoni G, Mattei F, Di Pucchio T, Santini SM, Bracci L, Belardelli F, Proietti E. Schiavoni G, et al. Blood. 2000 Mar 15;95(6):2024-30. Blood. 2000. PMID: 10706870 Free article.

3

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation.

Mattei F, Schiavoni G, Belardelli F, Tough DF. Mattei F, et al. Among authors: schiavoni g. J Immunol. 2001 Aug 1;167(3):1179-87. doi: 10.4049/jimmunol.167.3.1179. J Immunol. 2001. PMID: 11466332

4

ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC 3rd, Belardelli F, Gabriele L. Schiavoni G, et al. J Exp Med. 2002 Dec 2;196(11):1415-25. doi: 10.1084/jem.20021263. J Exp Med. 2002. PMID: 12461077 Free PMC article.

5

ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells.

Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, Morse HC 3rd, Belardelli F, Gabriele L. Schiavoni G, et al. Blood. 2004 Mar 15;103(6):2221-8. doi: 10.1182/blood-2003-09-3007. Epub 2003 Nov 13. Blood. 2004. PMID: 14615368 Free article.

6

Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway.

Schiavoni G, Mauri C, Carlei D, Belardelli F, Pastoris MC, Proietti E. Schiavoni G, et al. J Immunol. 2004 Jul 15;173(2):1266-75. doi: 10.4049/jimmunol.173.2.1266. J Immunol. 2004. PMID: 15240719

7

ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells.

Mattei F, Schiavoni G, Borghi P, Venditti M, Canini I, Sestili P, Pietraforte I, Morse HC 3rd, Ramoni C, Belardelli F, Gabriele L. Mattei F, et al. Among authors: schiavoni g. Blood. 2006 Jul 15;108(2):609-17. doi: 10.1182/blood-2005-11-4490. Epub 2006 Mar 28. Blood. 2006. PMID: 16569763 Free article.

8

Type I IFN regulate DC turnover in vivo.

Mattei F, Bracci L, Tough DF, Belardelli F, Schiavoni G. Mattei F, et al. Among authors: schiavoni g. Eur J Immunol. 2009 Jul;39(7):1807-18. doi: 10.1002/eji.200939233. Eur J Immunol. 2009. PMID: 19544312 Free article.

9

Regulation of immune cell homeostasis by type I interferons.

Mattei F, Schiavoni G, Tough DF. Mattei F, et al. Among authors: schiavoni g. Cytokine Growth Factor Rev. 2010 Aug;21(4):227-36. doi: 10.1016/j.cytogfr.2010.05.002. Epub 2010 Jun 2. Cytokine Growth Factor Rev. 2010. PMID: 20627800 Review.

10

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.

Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, Gabriele L, Proietti E, Bracci L. Schiavoni G, et al. Cancer Res. 2011 Feb 1;71(3):768-78. doi: 10.1158/0008-5472.CAN-10-2788. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156650

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters